Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter

Alzheimers Dement. 2022 Nov 16. doi: 10.1002/alz.12864. Online ahead of print.

Menglan Pang^{1

2}, Ling Zhu^{1

2}, Audrey Gabelle^{1

2}, Arie R Gafson^{1

2}, Robert W Platt³, James E Galvin⁴, Pierre Krolak-Salmon^{5

6}, Ivana Rubino², Carl de Moor^{1

2}, Shibeshih Belachew^{1

2}, Changyu Shen^{1

2}

¹ Biogen Digital Health, Biogen, Cambridge, Massachusetts, USA.
² Biogen, Cambridge, Massachusetts, USA.
³ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
⁴ Department of Neurology, Comprehensive Center for Brain Health, University of Miami Miller School of Medicine, Boca Raton, Florida, USA.
⁵ Clinical and Research Memory Center of Lyon (CMRR Lyon), Lyon Institute for Aging, University Hospital of Lyon (Hospices Civils de Lyon), Lyon, France.
⁶ Neuroscience Research Centre of Lyon, Lyon, France.

No abstract available

Publication types